Bard picks up Spire's hemodialysis catheter unit
This article was originally published in The Gray Sheet
Executive Summary
Spire will divest its hemodialysis catheter business to Bard for $15 million under an agreement announced Sept. 9. Spire says it will now refocus on its solar energy equipment business